NeOnc’s $629K Insider Buying Spree Follows Breakthrough Data and Now All Eyes Turn to the FDA
NeOnc NASDAQ: NTHI) executives have made approximately $629,000 in insider buys since announcing its Phase 2a results on August 12.
NeOnc NASDAQ: NTHI) executives have made approximately $629,000 in insider buys since announcing its Phase 2a results on August 12.